Human Molecular Genetics, 2001, Vol. 10, No. 11 1155-1162
© 2001 Oxford University Press
hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decay
1The University of Birmingham CRC Institute for Cancer Studies, Vincent Drive, Edgbaston, Birmingham B15 2TT, UK, 2School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK and 3Department of Experimental Pathology and Medicine, II Faculty of Medicine, University La Sapienza, Rome, Italy
We showed recently that mutation of the hMRE11 gene identified a new ataxia telangiectasia-like disorder (ATLD). In this report we describe the genomic organization of the hMRE11 gene and the analysis of a promoter region that appears to direct the divergent transcription of hMRE11 and the adjacent gene. The characterization of the genomic organization of the hMRE11 gene allowed us to determine the basis of an apparent null hMRE11 allele present in the mother and two patients in one of our two ATLD families. Polymorphic markers in the hMRE11 gene, including the promoter region, provided evidence that the mutated maternal allele was not deleted. An exon by exon search revealed the presence of a missense mutation in exon 15, the effect of which was to create a premature termination codon. Transcripts derived from the mutant allele were found to be subject to nonsense-mediated mRNA decay (NMD). Therefore, this allele was effectively null, because little if any mRNA from it was available for translation. The ATLD patients carrying this protein-truncating hMRE11 mutation have survived because the null allele they inherited from their mother is present with a missense mutation inherited from their father, which is expressed as normal levels of partially functional MRE11 protein. The mutation in the maternal hMRE11 allele of family 2 was also identified in a further unrelated Italian family with ATLD and also found to be subject to NMD.
+ To whom correspondence should be addressed. Tel: +44 121 414 4479; Fax: +44 121 414 4486; Email: p.j.byrd@bham.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. N. Acharya, A. M. Many, A. P. Schroeder, F. M. Kennedy, O. P. Savytskyy, J. T. Grubb, J. A. Vincent, E. A. Friedle, M. Celerin, D. S. Maillet, et al. Coprinus cinereus rad50 Mutants Reveal an Essential Structural Role for Rad50 in Axial Element and Synaptonemal Complex Formation, Homolog Pairing and Meiotic Recombination Genetics, December 1, 2008; 180(4): 1889 - 1907. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Dery, Y. Coulombe, A. Rodrigue, A. Stasiak, S. Richard, and J.-Y. Masson A Glycine-Arginine Domain in Control of the Human MRE11 DNA Repair Protein Mol. Cell. Biol., May 1, 2008; 28(9): 3058 - 3069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A M R Taylor and P J Byrd Molecular pathology of ataxia telangiectasia J. Clin. Pathol., October 1, 2005; 58(10): 1009 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fernet, M. Gribaa, M. A.M. Salih, M. Z. Seidahmed, J. Hall, and M. Koenig Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder Hum. Mol. Genet., January 15, 2005; 14(2): 307 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Delia, M. Piane, G. Buscemi, C. Savio, S. Palmeri, P. Lulli, L. Carlessi, E. Fontanella, and L. Chessa MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder Hum. Mol. Genet., September 15, 2004; 13(18): 2155 - 2163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lahdesmaki, A. M. R. Taylor, K. H. Chrzanowska, and Q. Pan-Hammarstrom Delineation of the Role of the Mre11 Complex in Class Switch Recombination J. Biol. Chem., April 16, 2004; 279(16): 16479 - 16487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Heikkinen, S-M Karppinen, Y Soini, M Makinen, and R Winqvist Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility J. Med. Genet., December 1, 2003; 40(12): e131 - 131. [Full Text]
|
|
|
|
|
|
F. Pagani, E. Buratti, C. Stuani, and F. E. Baralle Missense, Nonsense, and Neutral Mutations Define Juxtaposed Regulatory Elements of Splicing in Cystic Fibrosis Transmembrane Regulator Exon 9 J. Biol. Chem., July 11, 2003; 278(29): 26580 - 26588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Saviozzi, A Saluto, A M R Taylor, J I L Last, F Trebini, M C Paradiso, E Grosso, A Funaro, G Ponzio, N Migone, et al. A late onset variant of ataxia-telangiectasia with a compound heterozygous genotype, A8030G/7481insA J. Med. Genet., January 1, 2002; 39(1): 57 - 61. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Stankovic, G. S. Stewart, C. Fegan, P. Biggs, J. Last, P. J. Byrd, R. D. Keenan, P. A. H. Moss, and A. M. R. Taylor Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage Blood, January 1, 2002; 99(1): 300 - 309. [Abstract] [Full Text] [PDF]
|
|